![]() In hospitalized patients, in whom both hyperglycemia and hypoglycemia are associated with increased morbidity, mortality, and length of hospital stay, an insulin regimen is the preferred treatment. However, this necessary intensification of insulin therapy is often associated with a decrease in quality of life and an increase in treatment costs, and the risk of hypoglycemia. Good control implies a constant optimization of therapy, including insulin therapy, when needed. In clinical practice, the main objective is to ensure that patients maintain optimal glycemic control in order to prevent these complications. Type 2 diabetes is a chronic and progressive disease characterized by a state of hyperglycemia associated with micro and macrovascular complications. These findings suggest that continuous glucose monitoring can improve time-in-range and prevent hyperglycemia. No difference was observed in mortality, length of stay, or in infection rate ( p = 1.000, p = 0.455, and p = 0.606, respectively).Ĭonclusions: This retrospective study supports the use of continuous glucose monitoring in optimizing glycemic control in hospitalized patients with type 2 diabetes on intensive insulin therapy. 206.5 mg/dL, p < 0.001) was also observed in this group. 27.5%, p = 0.001), with no difference in the percentage of hypoglycemia occurence (1% vs. Continuous glucose monitoring users had a higher number of readings per day (six vs. Results: Both groups were comparable in terms of demographic and clinical characteristics. Research design and methods: This was a retrospective, cohort study of 60 hospitalized patients with type 2 diabetes, divided into two groups of 30 individuals each: an intervention group monitored through continuous glucose monitoring and a control group using capillary blood glucose. ![]() Additionally, we assessed the intervention's impact on reducing the length of hospital stay, mortality rates, and incidence of inpatient infections. The secondary endpoints included the assessment of reductions in hypoglycemia incidence, mean glucose levels, and glucose coefficient of variation. Objective: The primary endpoint of this study was to assess the increase in time-in-range (glycemic readings between 100-180 mg/dL) in hospitalized patients with continuous glucose monitoring, compared to capillary blood glucose. In hospitalized patients, studies using continuous glucose monitoring have focused mainly on evaluating its accuracy and feasibility, but the results were unclear on whether continuous glucose monitoring was superior to capillary blood glucose in improving glycemic control and further research is needed to support the use of these devices in hospitalized patients with diabetes. These devices are especially important for people with diabetes treated with insulin therapy and have been extensively studied in outpatient settings. Introduction: The emergence of continuous glucose monitoring devices revolutionized the monitoring of diabetes, allowing real-time measurement of interstitial glucose levels.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |